Biomark Diagnostics Inc. Stock Canadian Securities Exchange
Equities
BUX
CA09073K1084
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.305 CAD | 0.00% | +5.17% | +19.61% |
Sales 2022 | 0.04 0.06 | Sales 2023 | 0.15 0.21 | Capitalization | 15.37M 20.96M |
---|---|---|---|---|---|
Net income 2022 | -1M -1.36M | Net income 2023 | -1M -1.36M | EV / Sales 2022 | 392,262,031 x |
Net Debt 2022 | 1.58M 2.16M | Net Debt 2023 | 1.58M 2.15M | EV / Sales 2023 | 110,415,720 x |
P/E ratio 2022 |
-9.98
x | P/E ratio 2023 |
-8.29
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 49.76% |
1 week | +5.17% | ||
Current month | +1.67% | ||
1 month | -1.61% | ||
3 months | +8.93% | ||
6 months | +10.91% | ||
Current year | +19.61% |
Managers | Title | Age | Since |
---|---|---|---|
Rashid Maula Bux
FOU | Founder | - | 14-06-18 |
Guoyu Huang
DFI | Director of Finance/CFO | - | 17-06-14 |
Chief Tech/Sci/R&D Officer | - | 21-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rashid Maula Bux
FOU | Founder | - | 14-06-18 |
Bram Ramjiawan
BRD | Director/Board Member | - | 14-09-10 |
Brian Cheng
CTO | Chief Tech/Sci/R&D Officer | - | 14-09-10 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 0.305 | +1.67% | 32,500 |
24-04-24 | 0.3 | -4.76% | 9,000 |
24-04-23 | 0.315 | +8.62% | 4,000 |
24-04-22 | 0.29 | -3.33% | 9,000 |
24-04-19 | 0.3 | +3.45% | 1,750 |
Delayed Quote Canadian Securities Exchange, April 25, 2024 at 12:55 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-20.53% | 10.67B | |
+41.94% | 3.22B | |
-36.56% | 2.09B | |
-18.92% | 2.04B | |
-29.19% | 1.46B | |
+15.73% | 1B | |
-4.37% | 734M | |
-37.00% | 391M | |
-46.73% | 379M |
- Stock Market
- Equities
- 20B Stock
- BUX Stock